pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,878 catalysts · 4,876 phase readout · 2,332 8k filing · 286 earnings · 274 pdufa · 129 phase 2 completion · 61 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: grant×type: approval×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,332
  • earnings286
  • pdufa274
  • phase 2 completion129
  • phase 1 completion61
phase 1 initiation
32
  • phase 1 2 completion28
  • phase 0 trial completion22
  • phase 2 initiation16
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›COMPLETEDphase readoutNCT06112249: SAFE Workplace Intervention for People With IDD

    Sponsor: Temple University. Phase: NA. Conditions: Communicable Diseases, Prevention, Workplace Intervention

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07329049: The Effect of Inspiratory Muscle Training on Cognitive Functions, Cerebral Oxygenation, and Neurotrophic Factor Level in Patients With Obstructive Sleep Apnea Syndrome

    Sponsor: Istinye University. Phase: NA. Conditions: Obstructive Sleep Apnea Syndrome (OSAS)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06672549: A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

    Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Obesity, Overweight

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03346538: Dose Finding Study of MCI-186 in Acute Ischemic Stroke

    Sponsor: Shionogi. Phase: PHASE2. Conditions: Acute Ischemic Stroke

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03496649: Pubalgia and Adductor Tendinopathies Refractory to Medical Treatment

    Sponsor: University Hospital, Bordeaux. Phase: PHASE2. Conditions: Groin Injury, Tendinopathy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07616648: Effects of Opioid Drugs on Sleep and Emotion in Patients With Moderate to Severe Cancer Pain

    Sponsor: First Affiliated Hospital of Zhejiang University. Phase: . Conditions: Moderate to Severe Cancer Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05934747: Aim 3 Particle Swarm Optimization PIGD

    Sponsor: University of Minnesota. Phase: NA. Conditions: Parkinson's Disease and Parkinsonism

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06119581: A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

    Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07613528: Individualized Prolonged Luteal Support After Fresh Embryo Transfer in Women With Low Progesterone

    Sponsor: University Hospital, Montpellier. Phase: PHASE3. Conditions: Pregnancy, Progesterone Supplementation, Low Serum Progesterone

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07612865: People's Hospital of Xinjiang Uygur Autonomous Region

    Sponsor: People's Hospital of Xinjiang Uygur Autonomous Region. Phase: NA. Conditions: Cervical Cancer, Venous Thromboembolism, Lymphedema

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07381465: Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus

    Sponsor: Chinese SLE Treatment And Research Group. Phase: PHASE4. Conditions: Lupus Erythematosus, Systemic

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07431411: Reproductive Health Education, Birth Control and Sexual Quality of Life in Ectopic Pregnancy

    Sponsor: Buket Kömürcü. Phase: NA. Conditions: Ectopic Pregnancy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07396311: Fractional Exhaled Nitric Oxide and Exacerbations of COPD

    Sponsor: Chang Gung Memorial Hospital. Phase: . Conditions: Chronic Obstructive Pulmonary Disease (COPD)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07436611: Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains

    Sponsor: AFT Pharmaceuticals, Ltd.. Phase: PHASE2. Conditions: Port Wine Stains

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06704971: Assessing Cognitive Decline at Home

    Sponsor: Stanford University. Phase: . Conditions: Mild Cognitive Impairment, Mild Dementia, Dementia Alzheimers, Dementia, Memory Impairment, NPS

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05765344: Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function

    Sponsor: Gilead Sciences. Phase: PHASE1. Conditions: Hepatic Impairment, Healthy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07637734: Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)

    Sponsor: Verrica Pharmaceuticals Inc.. Phase: PHASE3. Conditions: Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (HPV), Warts

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05858034: Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older

    Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: HIV, Aging

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05959434: Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD

    Sponsor: Texas A&M University. Phase: PHASE2. Conditions: Posttraumatic Stress Disorder, Alcohol Use Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06626334: Blue Light as an Anti-inflammatory and Analgesic Strategy in Thoracic Trauma

    Sponsor: Rebecca E Kotcher, MD. Phase: NA. Conditions: Rib Fractures, Pain, Acute

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04994132: A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

    Sponsor: Children's Oncology Group. Phase: PHASE3. Conditions: Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma, Metastatic Embryonal Rhabdomyosarcoma, Metastatic Rhabdomyosarcoma, Solid Alveolar Rhabdomyosarcoma, Spindle Cell Rhabdomyosarcoma, Spindle Cell/Sclerosing Rhabdomyosarcoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06827132: Observational Study Evaluate Pathology Practice Use Artificial Intelligence in Patient Suspected Lung and Breast Cancer

    Sponsor: AstraZeneca. Phase: . Conditions: Lung Cancer, Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06786832: Characterization, Treatment, and Long-term Follow-up of Fatigued Patients in Primary Care

    Sponsor: Karolinska Institutet. Phase: NA. Conditions: Fatigue, Fatigue Post Viral, Exhaustion Disorder, Fatigue Symptom, Fatigue Related to Cancer Treatment

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07374198: Effect of Continuous Intraoperative Esketamine Infusion on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Mild-to-Severe Depression

    Sponsor: Chinese PLA General Hospital. Phase: NA. Conditions: Depression, Anxiety, S-ketamine, Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07505563: MiniFlo for Advanced Dupuytren's Disease

    Sponsor: Azienda Ospedaliera Universitaria Integrata Verona. Phase: NA. Conditions: Dupuytren's Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07256093: The Effectiveness of Acceptance and Commitment Therapy (ACT) on Dysfunctional Attitudes and Difficulties in Emotion Regulation Among University Students in Malaysia

    Sponsor: Universiti Sains Malaysia. Phase: NA. Conditions: Anxiety, Depression, Stress

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05803421: A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

    Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Type 2 Diabetes, Obesity, Overweight or Obesity, Overweight, Cardiovascular Diseases, Chronic Kidney Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07700121: PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma

    Sponsor: Abramson Cancer Center at Penn Medicine. Phase: EARLY_PHASE1. Conditions: Unresectable or Metastatic Melanoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06327321: Vitiligo Treatment by Targeting TYK2 Mediated Responses

    Sponsor: Centre Hospitalier Universitaire de Nice. Phase: PHASE2. Conditions: Vitiligo, Generalized

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07415616: Cold vs Warm Enteral Feeding and Gastric Emptying in Adult ICU Patients

    Sponsor: Bursa Yuksek Ihtisas Training and Research Hospital. Phase: NA. Conditions: Gastric Emptying, Enteral Nutrition (Food for Special Medical Purposes)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07579416: Bruxism, Anxiety, and Periodontal Status Among Dental Students

    Sponsor: Al-Hawash Private University. Phase: . Conditions: Bruxism, Anxiety

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07477704: A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

    Sponsor: Regeneron Pharmaceuticals. Phase: PHASE2. Conditions: Hypercholesterolemia

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07382804: Mobile Behavioral Activation Program With Wearable Sensors and Secure Activity Verification

    Sponsor: Truway Health, Inc.. Phase: NA. Conditions: Health Behavior, Behavioral Activation, Sedentary Behavior

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07680504: A Pilot Superiority Study Comparing the Efficacy of a Combination of a Glenohumeral Intra-articular Injection With a Suprascapular Nerve Block Versus a Glenohumeral Intra-articular Corticosteroid Injection in Retractile Capsulitis

    Sponsor: Nantes University Hospital. Phase: PHASE2. Conditions: Retractile Capsulitis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05139004: 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome

    Sponsor: City of Hope Medical Center. Phase: PHASE1. Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07383584: The Impact of Extending Sleep Before Joint-replacement Surgery on Post-surgical Pain

    Sponsor: Defense and Veterans Center for Integrative Pain Management. Phase: NA. Conditions: Joint (Knee or Hip Replacement)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07698184: The Condition of the Temporomandibular Joint in Hemiplegia

    Sponsor: Ayşe Ukbe Baykut. Phase: . Conditions: Hemiplegia, Temporomandibular Disorder (TMD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00009633: Follow-up Visit of High Risk Infants

    Sponsor: NICHD Neonatal Research Network. Phase: . Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07664033: AI-based Model for Rehabilitation Engagement and Motor Performance Evaluation in Pediatric Patients: A Pilot Study

    Sponsor: IRCCS Eugenio Medea. Phase: NA. Conditions: Neuromotor Impairments

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03489733: Prevention of Allergic Diseases in Infants

    Sponsor: HiPP GmbH & Co. Vertrieb KG. Phase: NA. Conditions: Atopic Diseases

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT05967533: The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors

    Sponsor: University of California, Davis. Phase: PHASE1. Conditions: Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Melanoma, Advanced Renal Cell Carcinoma, Advanced Triple-Negative Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer (AJCC) v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Stage III Colorectal Cancer AJCC v8, Stage III Lung Cancer AJCC v8, Stage III Renal Cell Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06508333: Efficacy and Safety of Vitamin D Supplementation Combined With Alarm Therapy in Treating Nocturnal Enuresis

    Sponsor: Xing Liu. Phase: NA. Conditions: Enuresis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05863052: Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

    Sponsor: University of Oklahoma. Phase: . Conditions: Immune Checkpoint Inhibitors, Metastatic Solid Tumor, Nonsmall Cell Lung Cancer, Melanoma, Renal Cell Carcinoma, Gastrointestinal Cancer, Squamous Cell Carcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04529252: Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases

    Sponsor: Mayo Clinic. Phase: . Conditions: Spinocerebellar Ataxias, Cerebellar Ataxia, Nucleotide Repeat Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04544852: Uncovering and Overcoming the Barriers of Colorectal Cancer Screening Amongst Spouses of Patients With Colorectal Cancer

    Sponsor: National University Health System, Singapore. Phase: NA. Conditions: Colorectal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03997552: NIPSA Versus Marginal Approach by Palatal Incision and MIST in Periodontal Regeneration

    Sponsor: Universidad de Murcia. Phase: NA. Conditions: Periodontitis, Periodontal Diseases, Periodontal Pocket

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07689188: Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa

    Sponsor: Harrison Dermatology. Phase: PHASE2. Conditions: Hidradenitis Suppurativa (HS)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06408103: Efficacy of a Multicomponent Intervention on Cognitive Function for the Caregiver-patient Dyad

    Sponsor: Universidad de Santander. Phase: NA. Conditions: Mild Cognitive Impairment

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07524803: Lung Cancer Screening for Early Detection of Suspicious Lung Nodules in Latin America(LUCAS-LATAM)

    Sponsor: Latin American Consortium for the Lung Cancer Research. Phase: . Conditions: Lung Cancer Screening

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06280703: A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

    Sponsor: Eli Lilly and Company. Phase: PHASE1. Conditions: Healthy, Type 1 Diabetes Mellitus

    full page →ctgov ↗
    ← prev
    page 86 of 98
    next →